novel coronavirus (2019-nCoV) 病毒：新型冠状病毒 2019-nCoV

Brazilian Covid strain found in UK raising fears over vaccine protection - BBC News

•Feb 28, 2021
BBC News
Six cases of the new Brazilian variant of coronavirus have been detected in the UK for the first time, three in England and three in Scotland. All but one of the cases are linked to travel from Brazil. Public Health England said the risk to the wider community is considered low, but it has increased testing in the South Gloucestershire area, where two of the cases were found. There are concerns that the Brazilian variant may be more contagious than the original virus and less likely to be contained by the existing vaccines. Reeta Chakrabarti presents BBC News at Ten reporting by health correspondent Catherine Burns.

Coronavirus Variant Found in Brazil Can Cause Reinfection, Study Shows

The first detailed studies of the so-called P.1 variant show how it spread in the Amazonian city of Manaus. Here’s the latest Covid-19 news.

Behind the Lines of Britain’s Covid-19 War

The government has laid out plans for reopening. But in cramped intensive care wards, teeming with patients and doctors near despair, the battle is unrelenting.

J&J’s Covid Vaccine Could Protect Millions -- If People Take It

The key will be assuring people that the single-shot vaccine is worth taking.

Tracking the Spread of the Coronavirus Outbreak in the U.S.

CDC Recommends Johnson & Johnson’s One-Shot Vaccine Angelica LaVito and Josh Wingrove

As School Closures Near First Anniversary, a Diverse Parent Movement Demands Action

Frustrated with remote learning, parents in the Philadelphia area are running for office, suing, relocating or retreating to private school.

Teacher Vaccine Eligibility Expands in States Where Supply Lags

L.A. County teachers, some essential workers eligible for vaccine starting Monday

The newly eligible workers will be able to make appointments starting Monday, but only a small number of first-dose appointments will be available.

Pa. eases restrictions and ends travel quarantine; N.J. expands vaccine eligibility; colleges plan for in-person fall semester

by Rob Tornoe, Laura McCrystal, Allison Steele and Robert Moran

Coronavirus Testing Slumps in the U.S.

Medical experts cited various factors behind the 30 percent drop in the country’s screening in recent weeks. Here’s the latest pandemic news.

Thousands of Farmworkers Are Prioritized for the Coronavirus Vaccine

A landmark initiative in California is taking vaccines to the fields, targeting a high-risk immigrant work force, many of whom are undocumented.

For a crematorium worker, COVID-19’s mounting toll is measured in ashes and anguish

We’re having trouble recognizing each other in masks, and it’s getting awkward

New York Covid-19 Variant Expands Reach in U.S. With 735 Cases

Early studies suggest the mutation may evade antibody therapy.

Philly’s first federal COVID-19 mass vaccination site already is having to fend off people who aren’t eligible

by Jason Laughlin

Canceling hundreds of appointments made by people who shouldn't yet be vaccinated became a major time investment on the first day of a federal mass vaccination site in Philadelphia.

U.S. Rep. Scanlon: Pa. admits vaccine undersupply in Philadelphia suburbs, promises to fix it with extra doses immediately

by Maria Panaritis The Pa. Secretary of Health's acknowledgement followed an Inquirer analysis showing Bucks, Delco, Montgomery and Chester Counties got less COVID-19 vaccine than many smaller counties.

#Coronavirus #Vaccines #EuropeanUnion

Who's to blame for the EU's slow coronavirus vaccine rollout? | DW News

•Feb 25, 2021 DW News

The EU has been slow off the mark in its vaccination drive, and new infection numbers are still stubbornly high in many countries. Germany currently has an incidence rate of 61 per 100,000. Sweden and the Czech Republic have more than 200. DW Brussels correspondent Max Zander takes a look at the challenges the EU faces going forward, and DW speaks with Manfred Weber, Member of the European Parliament. Vaccines, variants and freedom of movement. About a year into the pandemic, the EU is struggling to keep up with recent developments as Council president Charles Michel made clear in his invitation letter to the two day leaders conference.

#BBCNews

World's first doses of Covax vaccines delivered - BBC News

•Feb 24, 2021 BBC News

Ghana has become the first recipient of Covid-19 vaccine doses distributed by the global vaccine sharing initiative, Covax. A plane carrying 600,000 doses of the of the AstraZeneca/Oxford vaccine landed in the capital, Accra, on Wednesday. The Covax scheme aims to reduce the divide between rich countries and poorer nations unable to buy doses. The programme is planning to deliver about two billion vaccine doses globally by the end of the year.

Ghana Is First Nation to Get Free Covid-19 Vaccines Under Covax Plan

Inside a Covid I.C.U., Through a Nurse's Eyes | NYT Opinion

•Feb 25, 2021 The New York Times
The short film above allows you to experience the brutality of the pandemic from the perspective of nurses inside a Covid-19 intensive care unit. Opinion Video producer Alexander Stockton spent several days reporting at the Valleywise Medical Center in Phoenix. Two I.C.U. nurses wore cameras to show what it’s like to care for the sickest Covid patients a year into the pandemic. So many Americans have died in hospitals without family by their side, but they were not alone. Nurses brush patients’ teeth, change their catheters and hold their hands in their final moments. In just a year, we’ve lost half a million Americans to Covid-19. Vaccinations may be offering some relief, but inside I.C.U.s, nurses continue to contend with the trauma and grief of America’s carousel of death.

Opinion

One I.C.U., Two Nurses With Cameras. Here’s What They Saw.

“Nobody can ever even imagine what goes on in there.”

#VaccinePassport #EuropeanUnion #Pandemic

EU leaders agree to introduce COVID-19 vaccine passports | DW News

•Feb 26, 2021 DW News

The European Union has agreed to develop a COVID-19 vaccine passport that could ease border crossings, and allow people more freedom to travel again. EU leaders met for a virtual summit to discuss coordination. They're already under pressure over a lagging vaccine rollout. German Chancellor Angela Merkel says it will be at least three months before a vaccine passport system is up and running.With slow vaccinations, coronavirus Variants , border chaos and summer holidays at risk – there was no shortage of talking points at this virtual EU summit.During a four hour video call leaders tried to find a united way forward in the fight against the pandemic. The pressure is intense, concerns can't just be waved aside with the EU lagging behind on vaccination numbers and new variants spreading rapidly across the continent.Apart from ramping up vaccine manufacturing and easing production bottlenecks the EU will put more energy into detecting these more contagious and dangerous mutations through a dedicated program. With spring on its way tourism has made it back to the agenda. Greek Prime Minister Kyriakos Mitsotakis was one of the first leaders to call for an EU-wide vaccination certificate in an attempt to ease travel restrictions and save the summer holiday season. That’s something all leaders could get behind. But how and when exactly this - vaccine passport - could be rolled out is uncertain. But for the moment, member states have agreed that tourism and all non-essential travel is not an option.

#Coronavirus #Mutation #B117

What do the current mutations mean for the coronavirus pandemic? | COVID-19 Special

•Jan 12, 2021 DW News
As it spreads, it's mutating, taking on new characteristics, that can make it harder to fight. New variants found in South Africa and the UK are more contagious - straining health services. Japan is trying to isolate a new variant from Brazil. There's no proof any of them are any deadlier, but the virus is constantly changing, and could eventually make vaccines less effective. South Africa just became the first African nation to surpass the 1 million mark for coronavirus cases, authorities worry about the spread of the new and potentially highly contagious variant detected in the country.

Vaccine Shipments Present a Security Challenge Worthy of a James Bond Film

Shipping companies are using kill switches, panic buttons, plainclothes guards, and tons of monitoring to ensure delivery.

By Thomas Buckley March 2, 2021, 12:01 AM EST

Germany Steps Up Virus Checks at French Border to Fight Variants

Alexei Anishchuk and Geraldine Amiel

A Covid Vaccine Side Effect, Enlarged Lymph Nodes, Can Be Mistaken for Cancer

The condition is becoming more common as immunization rates increase. Experts are suggesting ways to ease patients’ fears and avoid needless testing.

#SubstanceAbuse #Coronavirus #Lockdown

High on lockdown: Substance abuse during the pandemic | COVID-19 Special

•Feb 26, 2021 DW News
Actor Seth Rogen, is not alone. Celebrity or not – pandemic pot smokers are on the rise, according to a global survey of 55,000 respondents. Boredom and loneliness are the most frequently cited reasons. The same for consuming more alcohol. Take Australia – before the coronavirus arrived, six percent of respondents drank alcohol on a daily basis. That's surged to over 30 percent during the pandemic.

5 Pandemic Mistakes We Keep Repeating

We can learn from our failures.

FEBRUARY 26, 2021 Zeynep Tufekci Contributing writer at The Atlantic

https://www.theatlantic.com/ideas/archive/2021/02/how-public-health-messaging-backfired/618147/

Outside In | Race for Covid-19 vaccines only widens the rich-poor gap David Dodwell27 Feb 2021 - 1:46AM

Supreme Court Again Allows Indoor Church Services, Lifts Ban

Greg Stohr

We’ve taken a look at how COVID-19 continues to change daily life: in L.A., paper cranes representing lives lost spark a global movement; in the Central Valley, the long-awaited relief of a vaccine for two healthcare workers and their family; and in Mexico, a young Catholic priest tries to save his diocese from the virus.

It’s not yet clear whether getting vaccinated protects those around you. But researchers think it might.

People vaccinated against coronavirus may shed less virus and, therefore, transmit less disease to others, experts say.

By Lindsey Bever

Philippines Offers Sinovac Vaccine to Health Workers Against FDA Caution

FDA advisers endorse J&J coronavirus vaccine, paving the way for likely authorization this weekend

If cleared by the Food and Drug Administration, the shot would be the nation’s third vaccine and the only one that provides protection with a single dose. Experts said it could expedite efforts to inoculate Americans as virus variants spread.

By Carolyn Y. Johnson and Laurie McGinley

Feb 26, 2021

Johnson & Johnson Single-Shot COVID-19 Vaccine Candidate Unanimously Recommended for Emergency Use Authorization by U.S. FDA Advisory Committee

U.S. Awaits F.D.A.’s Green Light for Johnson & Johnson’s Vaccine

The agency is expected to formally approve the single-shot vaccine on Saturday, making a third option available in the U.S. Here’s the latest on Covid-19.

A small town in denial comes face to face with the virus

When covid-19 became a reality in Southern Illinois in November, flooding across the plains, it illuminated a deeper, underlying problem in small-town America. By Will Englund | Photos by Whitney Curtis for The Post

A New Coronavirus Variant Is Spreading in New York, Researchers Report

The variant contains a mutation thought to help the virus dodge the immune system, scientists said.

Attacks on Asian-Americans in New York Stoke Fear, Anxiety and Anger

Hate crimes involving Asian-American victims soared in New York City last year. Officials are grappling with the problem even as new incidents occur.

By Alexandra E. Petri and Daniel E. Slotnik Feb. 26, 2021

https://www.nytimes.com/2021/02/26/nyregion/asian-hate-crimes-attacks-ny.html?action=click&module=Well&pgtype=Homepage&section=New%20York

Opinion | Why the smartest Covid-19 solutions may not be the most rational

Andrew Sheng 27 Feb 2021 - 2:29AM

The wave of covid bankruptcies has begun

By Jonathan O'Connell and Anu Narayanswamy

John Lauerman and Jason Gale

Can a Vaccinated Person Still Spread the Coronavirus?

Iain Marlow and Jason Gale

What Are Vaccine Passports and How Would They Work?

Jason Gale

What We Know About the Impact of Covid-19 on Children

The Editorial Board

What It Will Take to Get Life Back to Normal

They Were on Equal Footing. Then the Ground Shifted.

A year of pandemic restrictions has meant some friends are flush and others foundering.

#BBCNews #Wuhan #Covid

Covid-19 and Wuhan: Why don't we know more? - BBC News

•Feb 12, 2021 BBC News
As countries scramble to protect themselves against Covid-19, the search for its origin continues.

Global COVID-19 deaths surpass 2.5 mln: Johns Hopkins University

Xinhua | Updated: 2021-02-26 03:54 NEW YORK

https://www.chinadaily.com.cn/a/202102/26/WS60380089a31024ad0baab1be.html

Johns Hopkins experts in global public health, infectious disease, and emergency preparedness have been at the forefront of the international response to COVID-19.

This website is a resource to help advance the understanding of the virus, inform the public, and brief policymakers in order to guide a response, improve care, and save lives.

https://coronavirus.jhu.edu/

Brazil Surpasses 250,000 Covid Deaths Amid Vaccination Hurdles

Danielle Chaves, Rachel Gamarski and Isadora Calumby

#BBCNews

UK considers “vaccine passports” to prove Covid protection - BBC News

•Feb 23, 2021 BBC News

The Final Push to End the Coronavirus Pandemic in the U.S.

Shots are going into more arms, but too many people could still fall through the cracks.

Vaccine Passport Finds Strong Support in U.K. Poll

FDA confirms Johnson & Johnson's COVID-19 vaccine works well

•Feb 24, 2021 CBS News
An FDA review released today confirms the single-dose Johnson & Johnson vaccine is both safe and effective against COVID-19, likely setting the stage for a third vaccine to be authorized for use in the U.S. Dr. Neeta Ogden joins CBSN with more.

F.D.A. Panel Gives Green Light to Johnson & Johnson’s Vaccine

Formal authorization is expected on Saturday, and the first shipments are likely to go out in the days after that. Here’s the latest on the pandemic.

Feb 26, 2021

Johnson & Johnson Single-Shot COVID-19 Vaccine Candidate Unanimously Recommended for Emergency Use Authorization by U.S. FDA Advisory Committee

J&J’s One-Shot Covid Vaccine Receives FDA Advisers’ Backing

FDA Advisers to Vet J&J’s One-Shot Vaccine for Emergency Use

Robert Langreth

J&J’s Covid-19 Vaccine Is Safe and Effective, FDA Says, Paving Way for Approval

Agency says the single-dose vaccine is 66.1% effective in preventing moderate to severe virus disease, and showed signs of slowing the virus’s spread

By Thomas M. Burton and Peter Loftus Updated Feb. 24, 2021 5:51 pm ET
https://www.wsj.com/articles/johnson-and-johnson-covid-19-vaccine-fda-review-11614118867

J&J Covid Vaccine Found Effective by FDA Before Panel Meets

J&J Shot to Get EU Nod in Early March, Easing Supply Squeeze

Insurer Warns of South African Death Spike in Covid Third Wave

Moderna’s Covid Deals Top $18 Billion; Medical Chief Exits

Moderna Announces it has Shipped Variant-Specific Vaccine Candidate, mRNA-1273.351, to NIH for Clinical Study

February 24, 2021 at 4:17 PM ESTPDF Version

Company also provides update on strategy for addressing SARS-CoV-2 variants of concern

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Feb. 24, 2021-- Moderna, Inc. (Nasdaq: MRNA)

https://investors.modernatx.com/news-releases/news-release-details/moderna-announces-it-has-shipped-variant-specific-vaccine

Pfizer-BioNTech Shot Could Help End Pandemic, Israel Study Shows

PFIZER AND BIONTECH INITIATE A STUDY AS PART OF BROAD DEVELOPMENT PLAN TO EVALUATE COVID-19 BOOSTER AND NEW VACCINE VARIANTS

Thursday, February 25, 2021 - 06:45am

The evaluation is part of the Phase 1/2/3 trial and will study a third dose of the Pfizer-BioNTech COVID-19 vaccine, BNT162b2, at 30 µg that will be given to Phase 1 participants to evaluate the safety and tolerability of a booster vaccine
Discussions with regulatory authorities are ongoing regarding an additional registration-enabling study using an mRNA vaccine with a variant sequence; this would provide a flexible solution for rapidly adapting the vaccine for use against the B.1.351 lineage or other new strains that may emerge as possible immune escape virus variants
Based on in-vitro studies conducted to date and observations from real world evidence, the Companies have not observed changes to neutralizing antibody levels that would predict a significant reduction in protection provided by two doses of BNT162b2

NEW YORK & MAINZ, Germany--(BUSINESS WIRE)-- Pfizer Inc. (NYSE: PFE) and BioNTech SE (Nasdaq: BNTX)

https://www.pfizer.com/news/press-release/press-release-detail/pfizer-and-biontech-initiate-study-part-broad-development

Coronavirus Updates

Study Finds Key Differences on 2 Ways Children Become Ill With Covid-19

Children hospitalized with acute Covid-19 seem to have symptoms and characteristics that differ from those with a Covid-linked inflammatory syndrome.

Lilly announces additional doses of neutralizing antibody therapy purchased by U.S. government to treat COVID-19

February 26, 2021 Download PDF INDIANAPOLIS, Feb. 26, 2021 /PRNewswire/ --

The U.S. government has agreed to purchase a minimum of 100,000 doses of bamlanivimab (LY-CoV555) 700 mg and etesevimab (LY-CoV016) 1400 mg together, Eli Lilly and Company (NYSE: LLY) announced. Bamlanivimab and etesevimab together recently received emergency use authorization for the treatment of recently diagnosed, mild to moderate COVID-19 in patients who are at high risk of progressing to severe COVID-19 and/or hospitalization.

https://investor.lilly.com/news-releases/news-release-details/lilly-announces-additional-doses-neutralizing-antibody-therapy

February 26, 2021 at 6:46 AM EST Back

EMA ISSUES ADVICE ON REGENERON'S ANTIBODY COCKTAIL (CASIRIVIMAB WITH IMDEVIMAB) FOR CERTAIN COVID-19 PATIENTS

TARRYTOWN, N.Y., Feb. 26, 2021 /PRNewswire/ --

EU member states can utilize the positive CHMP opinion when making national decisions about use of the antibody cocktail, prior to a potential future EMA market authorization

Regeneron has collaborated with Roche to develop and manufacture the antibody cocktail; Roche is responsible ex-U.S. and has already begun distribution in the EU

Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN)

https://investor.regeneron.com/index.php/news-releases/news-release-details/ema-issues-advice-regenerons-antibody-cocktail-casirivimab

Dismay Turns to Outrage as South America’s Powerful Jump the Vaccine Line

A wave of corruption scandals is exposing how the rich and well-connected got vaccinated early. Public outrage is growing.

Novavax and Takeda Finalize License Agreement for Novavax’ COVID-19 Vaccine Candidate in Japan; Takeda Initiates Phase 1/2 Trial in Japan

Feb 26, 2021 at 8:22 AM EST Download PDF

Agreement includes COVID-19 vaccine technology transfer to Takeda for local manufacturing and commercialization in Japan
Takeda doses first participant in immunogenicity and safety study to support local regulatory application

GAITHERSBURG, Md., February 25, 2021 -- Novavax, Inc. (Nasdaq: NVAX), a biotechnology company developing next-generation vaccines for serious infectious diseases, today announced progress in its collaboration with Takeda Pharmaceutical Company Limited, originally announced in August. The companies have signed an exclusive license agreement for Takeda’s development, manufacturing and commercialization of NVX‑CoV2373, Novavax’ COVID‑19 vaccine candidate, in Japan. Additionally, Takeda dosed the first participants in a Phase 1/2 clinical trial to test the immunogenicity and safety of Novavax’ vaccine candidate in the Japanese population.

https://ir.novavax.com/news-releases/news-release-details/novavax-and-takeda-finalize-license-agreement-novavax-covid-19

Japan embraces robot ‘pets’ as companions to ease pandemic isolation

•Feb 26, 2021 South China Morning Post

#Coronavirus #Pandemic #Lockdown

Coronavirus pandemic wreaks havoc in the student body | COVID-19 Special

•Feb 25, 2021 DW News

novel coronavirus (2019-nCoV) 病毒：新型冠状病毒 2019-nCoV

India donates COVID-19 vaccines to neighboring countries | DW News

•Feb 19, 2021 DW News

Brazil Hits 10 Million Covid Cases With New Strain Taking Hold
Julia Leite, Martha Beck and Caroline Aragaki

CDC Advisers Weigh Second-Shot Delay to Quicken Vaccine Uptake

Anna Edney

#CNN #News #CNNI

Wuhan's first virus outbreak could be bigger than we knew WHO says

•Feb 15, 2021 CNN
Investigators from the World Health Organization studying the origins of coronavirus in China have discovered signs the first outbreak in Wuhan in December 2019 may have been much wider than previously thought. CNN's Nick Paton Walks talks to lead investigator Peter Ben Embarek.

At least three WHO COVID-19 investigators linked with Chinese-institutions

•Feb 14, 2021 Sky News Australia

Coronavirus: A look inside China’s Wuhan Institute of Virology

Jul 8, 2020 South China Morning Post

Science

Coronavirus: facing criticism and attacks, WHO team readies report on Wuhan probe

Questions have been raised about the findings of the Covid-19 origins mission and the scientists’ access to information in China
All eyes are now on the official reports, with the first expected to be released this week

Simone McCarthy Published: 11:00am, 17 Feb, 2021
https://www.scmp.com/news/china/science/article/3121934/coronavirus-facing-criticism-and-attacks-who-team-readies-report

What WHO coronavirus investigators did and did not find out in Wuhan | DW News

Feb 10, 2021 DW News

#Gravitas #WHO #WuhanVirus

Gravitas: Wuhan virus origins probe: Is the WHO team divided over the results?

•Feb 11, 2021 WION

#Coronavirus #Disinformation #China

Did China deliberately spread disinformation about the coronavirus? | DW News

•Feb 15, 2021
China has responded with anger to allegations from the US that it withheld information about the origins of the COVID-19 outbreak last year. Beijing said Washington had quote 'already gravely damaged international cooperation on COVID- 19' and was now 'pointing fingers at other countries.' The comments come as the US said it had 'deep concerns' about China's handling of a WHO mission investigating the origins of the pandemic in the central city of Wuhan. The WHO team is expected to present their findings as early as this week. Several members of the team said they were happy with the access to information provided by China. But others including Australian microbiologist, Dominic Dwyer said China refused to give then RAW data on early COVID cases and that this could complicate efforts to understand how the outbreak began. With aspects of the WHO mission to China still unclear, the uncertainty over the origins of the coronavirus are compounded by a deliberate disinformation campaign by China.

#Coronavirus #Vaccine #Variants

Vaccine efficacy uncertain as coronavirus variants spread | DW News

•Feb 17, 2021 DW News

Pfizer Shot Elicits Fewer Antibodies Vs. South Africa Strain

By Naomi Kresge and Robert Langreth February 17, 2021, 5:00 PM EST Updated on February 17, 2021, 5:33 PM EST

Companies expect vaccine will still work against the variant
Study results published in New England Journal of Medicine

https://www.bloomberg.com/news/articles/2021-02-17/pfizer-shot-produces-fewer-antibodies-versus-south-africa-strain?srnd=premium

Mayo Clinic AI Study Shows Covid Shots Work Well in Real World

Two months after the first vaccines received U.S. clearance, the shots’ efficacy is holding up.

U.S. Schools Can and Should Open Faster

U.K. Approves Study That Will Deliberately Infect Volunteers With Virus

The idea of such a study, called a human challenge trial, has been hotly debated since the early months of the pandemic.

U.S. deaths are 500,000 higher than normal since the pandemic hit. Here’s the breakdown by state.

#Coronavirus #Medication #Treatment

Sidelined by vaccines? What’s the latest research on COVID medication and treatments?

Feb 16, 2021 DW News

Researchers have been working tirelessly to find an effective treatment for people with COVID-19. Vaccines are stealing the headlines and the financing. That's the main complaint of scientists in search of a COVID therapy. Treatments are still elusive, despite hundreds of drugs being developed or repurposed. But thousands of people are dying from the disease every day. Preventing it from killing people is vital. But doing so can take many forms. Here's a look at the most promising medications being tested.

EMA receives application for conditional marketing authorization of COVID-19 Vaccine Janssen

News 16/02/2021

EMA has received an application for conditional marketing authorisation (CMA) for a COVID-19 vaccine developed by Janssen-Cilag International N.V.

EMA’s human medicines committee (CHMP) will assess the vaccine, known as COVID-19 Vaccine Janssen, under an accelerated timetable. The Committee could issue an opinion by the middle of March 2021, provided the company’s data on the vaccine’s efficacy, safety and quality are sufficiently comprehensive and robust.
https://www.ema.europa.eu/en/news/ema-receives-application-conditional-marketing-authorisation-covid-19-vaccine-janssen?source=content_type%3Areact%7Cfirst_level_url%3Anews%7Csection%3Amain_content%7Cbutton%3Abody_link

Justin Fox

Is the Worst Over for Covid-19?

A spring wave may be in the cards, but it’s hard to say for sure. Here are the four main variables that will determine it.

#WorldNewsTonight #COVID19 #VaccinationSites

1st federal mass vaccination sites open in Los Angeles and Oakland | WNT

•Feb 16, 2021 ABC News

U.S. Vaccine Data Reveal Big Racial Gaps in Who’s Getting Shots: Covid-19 Tracker

FEBRUARY 17, 20211:16 AMUPDATED 7 HOURS AGO

Taiwan says BioNTech vaccine deal on hold, cites potential Chinese pressure

By Reuters Staff TAIPEI (Reuters)
https://www.reuters.com/article/us-health-coronavirus-taiwan/taiwan-says-biontech-vaccine-deal-on-hold-cites-potential-chinese-pressure-idUSKBN2AH0HE?source=content_type%3Areact%7Cfirst_level_url%3Anews%7Csection%3Amain_content%7Cbutton%3Abody_link

Taiwan suggests mainland China pressured BioNTech to abandon Covid-19 vaccine deal

European Commission Purchases Additional 150 Million Doses of COVID-19 Vaccine Moderna

February 17, 2021 at 7:12 AM EST PDF Version

150 million doses scheduled to be delivered in Q3 and Q4, 2021

With this new purchase, total of 310 million doses ordered by the European Commission to date for delivery in 2021

Contract includes an option to purchase an additional 150 million doses scheduled for delivery in 2022

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Feb. 17, 2021-- Moderna, Inc. (Nasdaq: MRNA), a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines, today announced that the European Commission purchased an additional 150 million doses of the COVID-19 Vaccine Moderna, which are scheduled to be delivered in the third and fourth quarter of 2021. This brings its confirmed order commitment to 310 million doses for delivery in 2021.

https://investors.modernatx.com/news-releases/news-release-details/european-commission-purchases-additional-150-million-doses-covid

Pfizer and BioNTech to Supply the European Union with 200 Million Additional Doses of COMIRNATY®

PDF Version

New agreement brings total supply to the European Union to 500 million doses, with delivery expected by the end of 2021
European Commission has the option to request an additional 100 million doses

NEW YORK and MAINZ, GERMANY, February 17, 2021 (GLOBE NEWSWIRE) — Pfizer Inc. (NYSE: PFE) and BioNTech SE (Nasdaq: BNTX) today announced an agreement with the European Commission (EC) to supply an additional 200 million doses of COMIRNATY®, the companies’ COVID-19 vaccine, to the 27 European Union (EU) member states. The EC has the option to request supply of an additional 100 million doses.

https://investors.biontech.de/news-releases/news-release-details/pfizer-and-biontech-supply-european-union-200-million-additional

White House Voices Skepticism on China’s Role in Covid-19 Probe

By Jenny Leonard February 13, 2021, 12:03 PM EST

Biden national security adviser Jake Sullivan issues statement
Criticism comes as WHO says probe hasn’t ruled out any cause

https://www.bloomberg.com/news/articles/2021-02-13/white-house-voices-skepticism-on-china-s-role-in-covid-19-probe?srnd=coronavirus

Millions of jobs unlikely to come back, even after pandemic, economists warn

Businesses are planning for a future of less business travel, more automation and more people working from home. By Heather Long

When Vaccinating Teachers Might Not Be Enough to Open Schools

Oregon is a case study in how Pacific Coast cities are lagging in resuming in-person teaching

Scientists Call on C.D.C. to Set Air Standards for Workplaces, Now

The agency has not fully reckoned with airborne transmission of the coronavirus in settings like hospitals, schools and meatpacking plants, experts said.

Coronavirus origins report has a lot riding on it, global health experts say

Questions have been raised about the findings of the Covid-19 origins mission and the scientists’ access to information in China. All eyes are now on the official reports, with the first expected to be released this week.

#BBCNews

Children take part in new trials for Oxford-AstraZeneca vaccine - BBC News

Feb 16, 2021 BBC News

#Gravitas #UK #NewCOVIDVariant

Gravitas: New variant of Wuhan virus discovered in the UK

•Feb 16, 2021 WION

novel coronavirus (2019-nCoV) 病毒：新型冠状病毒 2019-nCoV

#ABCNews #ABCNewsAustralia

Dr Norman Swan discusses Germany's concerns around the AstraZeneca vaccine in the elderly | ABC News

•Jan 28, 2021 ABC News (Australia) ABC News (Australia)

In race against time on virus mutations, U.S. is ‘falling behind’

America has done so little of the genetic sequencing needed to detect mutated versions of coronavirus, like those first discovered in Britain and South Africa, that such variants are likely proliferating quickly, undetected, experts said. By William Wan and Ben Guarino

U.S.

New Playbook for Covid-19 Protection Emerges After Year of Study, Missteps

Mask-wearing, good air flow and frequent rapid tests are more important than surface cleaning, temperature checks and plexiglass. Scientists say America needs to double down on protection protocols as potentially more-contagious coronavirus variants take hold and vaccines are slow to roll out.

https://www.wsj.com/articles/new-playbook-for-covid-19-protection-emerges-after-year-of-study-missteps-11611680950?mod=e2tw

Fauci calls variant spread within U.S. a ‘wake-up call’ as countries introduce new travel bans

New coronavirus variants — and more yet to come — will challenge existing vaccines’ effectiveness and require the continual production of new versions of vaccine directed at specific mutations, said Anthony S. Fauci, the top U.S. infectious-disease expert.By Erin Cunningham, Kim Bellware, Dan Diamond and Amanda Coletta

What you need to know about the coronavirus variants

Single-shot Johnson & Johnson vaccine prevents illness but shows the threat of variants

By Carolyn Y. Johnson

Tracking U.S. vaccinations by state

Coronavirus: new clinical trials raise fears the virus is learning how to resist vaccines

Laboratory tests had suggested that the vaccines authorized in the US trigger a smaller immune response to the South Africa variant
More than 100 million people have been infected worldwide, and each of those infections is an opportunity for the virus to randomly mutate

Associated Press Published: 5:10am, 31 Jan, 2021

https://www.scmp.com/news/world/europe/article/3119939/coronavirus-new-clinical-trials-raise-fears-virus-learning-how

Latest Covid Surge Appears to Flame Out Even in Worst Hot Spots

Covid Mutations Undercut Optimism Even as More Vaccines Get Near

J&J Single-Dose Vaccine Is 100% Effective at Preventing Deaths, Hospital Stays

U.S. Tests More for Variants; NYC to Ease Dining: Virus Update

Covid-19 Vaccine Tracker Frequently Asked Questions

Tallying Countries Vaccine Contracts: Covid-19 Deals Tracker

J&J’s Vaccine Results Are In. So What’s the Verdict?

As more of the variants are found in the U.S., the C.D.C. director says ‘we should be treating every case as if’ it is one.

The E.U. approves AstraZeneca’s vaccine and moves to restrict it from sending doses outside the bloc.

Johnson & Johnson Vaccine Works but Fuels Variant Concerns

The vaccine’s efficacy rate dropped from 72 percent in the U.S. to just 57 percent in South Africa, where a highly contagious variant is driving most cases.

HEALTH AND SCIENCE

Moderna asks FDA to authorize 5 additional doses per Covid vaccine vial to speed distribution, source tells CNBC

PUBLISHED FRI, JAN 29 20216:27 PM ESTUPDATED FRI, JAN 29 20218:20 PM EST Meg Tirrell KEY POINTS

Moderna is said to have asked the FDA to allow it to put additional doses in its vaccine vials.
The move is aimed at alleviating a bottleneck in Covid-19 vaccine manufacturing.
The change would add up to five doses to the 10-dose vials.

https://www.cnbc.com/2021/01/29/moderna-asks-fda-to-allow-more-doses-in-each-covid-19-vaccine-vial.html?source=content_type%3Areact%7Cfirst_level_url%3Anews%7Csection%3Amain_content%7Cbutton%3Abody_link

Lionel Laurent

Vaccine Trade Wars Have Just One Winner: Covid-19

Which vaccine should you get? Here’s what the experts say.

Vaccine Rollout Gives U.K. a Rare Win in Battling Pandemic

“Vaccination is the one thing we’ve gotten right.” Despite botching much of its pandemic response, Britain has managed one of the fastest rollouts.

A Pandemic Is Hard Enough. For Some, Being Single Makes It Harder.

How the Effort to Find Treatments for Covid-19 Faltered

Tracking Coronavirus Vaccinations Around the World

Almost 85 million vaccine doses have been administered worldwide, equal to 1.1 doses for every 100 people. Most countries have yet to give a single dose.

#ABCNews #ABCNewsAustralia

Wait times for elective surgery in Tasmania on the rise | ABC News

Jan 28, 2021 ABC News (Australia) ABC News (Australia)

Coronavirus updates: Variant found in South Africa prompts travel curbs; E.U. seeks answers on vaccine delays

The more virulent strain first found in South Africa presents a serious test to efforts to tame the pandemic, prompting governments to swiftly tighten borders.

By Erin Cunningham

U.S. handling of American evacuees from Wuhan increased coronavirus risks, watchdog finds

The first American evacuees from China were met last year by U.S. officials with no virus-prevention plan or infection control training, according to a federal investigation. By Dan Diamond

Pfizer, BioNTech Covid Vaccine Safe for the Elderly, EMA Says

Mexico’s Death Toll Becomes World’s Third Highest

As of Friday morning, Mexico had recorded 155,145 coronavirus deaths, more than in India. It has had more than 1.8 million cases.

World’s Most Vaccinated Nation Struggles With Virus Variants

Governments Sign Secret Vaccine Deals. Here’s What They Hide.

Multibillion-dollar contracts give drug makers liability shields, patent ownership and leeway on delivery dates and pricing.

Novavax’s Vaccine Works Well, Except on Variant Found in South Africa

An analysis in Britain found that the vaccine had an efficacy rate of nearly 90 percent. In a South Africa trial, the rate dropped to under 50 percent.

#Gravitas #Astrazeneca #Europe

Gravitas: Europe's vaccine rollout disaster

•Jan 28, 2021 WION WION

JANUARY 28, 20217:54 AM

German expert panel recommends giving AstraZeneca shot only to under 65s

By Reuters Staff BERLIN, Jan 28 (Reuters)

https://www.reuters.com/article/health-coronavirus-germany-astrazeneca/german-expert-panel-recommends-giving-astrazeneca-shot-only-to-under-65s-idUSS8N2J104Y?source=content_type%3Areact%7Cfirst_level_url%3Anews%7Csection%3Amain_content%7Cbutton%3Abody_link

First U.S. cases of South Africa virus variant reported in S.C.

Two people in South Carolina have been infected with the coronavirus variant, which has mutations that scientists say could allow the virus to elude some treatments and threaten vaccines’ effectiveness. Neither person had a recent history of travel.By Joel Achenbach and Carolyn Y. Johnson

What you need to know about the coronavirus variants

J&J Covid Vaccine Supply to Start at 2 Million Doses, GAO Says

NYC Asks Government Workers to Return to Office in May
Novavax Soars After Upbeat Results From Covid Vaccine Trial

Coronavirus variant sweeps South Africa, exhibiting ‘terrifying’ dominance

Ninety percent of new cases are of the variant, and excess mortality figures have spiked. By Lesley Wroughton and Max Bearak

Novavax COVID-19 Vaccine Demonstrates 89.3% Efficacy in UK Phase 3 Trial

Jan 28, 2021 at 4:05 PM EST Download PDF

First to Demonstrate Clinical Efficacy Against COVID-19 and Both UK and South Africa Variants

Strong efficacy in Phase 3 UK trial with over 50% of cases attributable to the now-predominant UK variant and the remainder attributable to COVID-19 virus
Clinical efficacy demonstrated in Phase 2b South Africa trial with over 90% of sequenced cases attributable to prevalent South Africa escape variant
Company to host investor conference call today at 4:30pm ET

GAITHERSBURG, Md., Jan. 28, 2021 (GLOBE NEWSWIRE) -- Novavax, Inc. (Nasdaq: NVAX), a biotechnology company developing next-generation vaccines for serious infectious diseases, today announced that NVX-CoV2373, its protein-based COVID-19 vaccine candidate, met the primary endpoint, with a vaccine efficacy of 89.3%, in its Phase 3 clinical trial conducted in the United Kingdom (UK). The study assessed efficacy during a period with high transmission and with a new UK variant strain of the virus emerging and circulating widely. It was conducted in partnership with the UK Government’s Vaccines Taskforce. Novavax also announced successful results of its Phase 2b study conducted in South Africa.

https://ir.novavax.com/news-releases/news-release-details/novavax-covid-19-vaccine-demonstrates-893-efficacy-uk-phase-3

It’s time to double or upgrade masks as virus variants emerge, experts say

By Fenit Nirappil

South African Covid Variant Detected for the First Time in U.S.

Pfizer CEO Says Science Will Prevail With Covid-19 Here to Stay

The latest pandemic work for women? Snagging vaccine appointments for their parents.

“It’s on me not because any brother or male relative refused to, but because I don’t think it occurred to them,” one Virginia woman said. By Soo Youn

A scathing new documentary from HBO alleges a Chinese cover-up on the coronavirus

How will the government react to an expose? By Steven Zeitchik

Coronavirus Updates

How the Coronavirus Turns the Body Against Itself

Some patients struggling with Covid-19 develop antibodies against their own tissues, scientists have found.

#WorldNewsTonight #PresidentJoeBiden #COVID19

Nationwide vaccine shortage as COVID-19 variant confirmed in half the country

•Jan 27, 2021 ABC News ABC News

Why Vaccines Might Not Be Able to Eliminate Covid-19

The road to eliminating Covid-19 is long and paved with uncertainty.

Coronavirus: Cambodian scientists find close match for pathogen in samples collected in 2010

Viral sequences in samples from horseshoe bats have 92 per cent similarity to Covid-19 pathogen, researchers say
Closest known relative to the coronavirus was a bat virus found in Yunnan province, which is a 96 per cent match

Simone McCarthy Published: 12:00pm, 28 Jan, 2021

https://www.scmp.com/news/china/science/article/3119537/coronavirus-cambodian-scientists-find-close-match-pathogen

How 425,000 Coronavirus Deaths Added Up

It took 44 days after the first U.S. coronavirus death was recorded to reach 25,000 deaths. The most recent 25,000 deaths came in a week.

European Union Vaccine Shortages Snowball Into a Crisis

Spain became the first country to partly suspend immunizations for lack of doses. New York may reopen indoor dining. Catch up on pandemic news.

Opinion Ezra Klein

The New Virus Strains Make the Next 6 Weeks Crucial

“Let’s not wait until we wrap the car around the tree to start pumping the brakes.”

Voices from the Pandemic

‘I was lucky to find this vaccine anywhere’

Stanley Plotkin, legendary vaccinologist, on the historic development and chaotic distribution of covid-19 vaccinesAs told to Eli Saslow

Health workers in the birthplace of the Brazil variant thought they’d seen the worst of the virus. They had no idea.

By Terrence McCoy and Heloísa Traiano

At first coronavirus briefing, White House acknowledges vaccinations will take months

Top administration officials launched regular briefings on their coronavirus response by seeking to illustrate their fidelity to science and transparency.

By Amy Goldstein and Lena H. Sun

EU's Vestager Says Astra Vaccine Delay Not About Bureaucracy

•Jan 27, 2021 Bloomberg Markets and Finance Bloomberg Markets and Finance

AstraZeneca and EU at loggerheads over COVID-19 vaccine supplies

Jan. 27, 2021 4:02 PM ET AstraZeneca PLC (AZN) By: Dulan Lokuwithana, SA News Editor

Tensions keep rising between British drug developer AstraZeneca (NASDAQ:AZN) and the European Union over the supply delays for the company’s coronavirus vaccine co-developed with the University of Oxford.
The 27-member bloc is far behind in the COVID-19 vaccination drive, with just over 2% of the region’s populations receiving at least one dose compared to over 40% in Israel and 10% in Britain.
https://seekingalpha.com/news/3655144-astrazeneca-and-eu-at-loggerheads-over-covid-19-vaccine-supplies

Tensions rise as AstraZeneca, EU spar over vaccine delays

By RAF CASERT, SAMUEL PETREQUIN and DANICA KIRKA

BRUSSELS (AP) — The European Union and drugmaker AstraZeneca sparred Wednesday over a delay in coronavirus vaccine deliveries amid a deepening dispute that raises concerns about international...

EU Officials Say Astra Pulls Out of Crunch Call on Vaccine Delay

E.U. vaccine feud with AstraZeneca bursts into the open; Biden vows to boost supply

By Erin Cunningham, Paul Schemm, Loveday Morris and Marisa Iati

U.S. Needs 500 Million Doses to Vaccinate Everyone 16 and Older

Biden officials set out another target for vaccination.

Pandemic Gets Increasingly Local as U.S. Cases Keep Dropping

More contagious virus variants have spread to dozens of countries, says WHO

Coronavirus: more contagious variants have spread to dozens of countries, says WHO

The strain first spotted in Britain has reached 70 countries, while the one first found in South Africa has spread to 31 countries A third variant, discovered in Brazil, is now in eight countries

Agence France-Presse Published: 1:54am, 28 Jan, 2021

https://www.scmp.com/news/world/article/3119526/coronavirus-more-contagious-variants-have-spread-dozens-countries-says

Moderna Confirms Discussions with U.S. Government for Additional 100 Million Doses of the Moderna COVID-19 Vaccine

January 27, 2021 at 8:20 AM ESTPDF Version

Would bring total to 300 million doses ordered by the U.S government to date

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Jan. 27, 2021-- Moderna, Inc. (Nasdaq: MRNA), a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines today confirmed that the Company is in discussion with the U.S. government to purchase an additional 100 million doses of the Moderna COVID-19 Vaccine for delivery in the third quarter of 2021.

https://investors.modernatx.com/news-releases/news-release-details/moderna-confirms-discussions-us-government-additional-100

The spread of other dangerous germs is surging — a result, in part, of the chaotic response to the pandemic.

Virus will kill many more, WH projects as briefings resume

By ZEKE MILLER and RICARDO ALONSO-ZALDIVAR

WASHINGTON (AP) — The Biden administration launched its new level-with-America health briefings Wednesday with a projection that as many as 90,000 more in the U.S. will die from the coronavirus in...

Full Coverage: Coronavirus pandemic

Why Delaying the Second Covid Vaccine Shot Is Messy

Over 6 Million Added to Food Stamp Rolls in Pandemic

Tracking Covid-19 Hospitalizations in the U.S.

The number of coronavirus cases in the U.S. is surging, and along with that are the number of hospitalizations. Track the number of hospitalizations by state.

The Latest: FEMA to reimburse states for some pandemic costs

SHAREMONDAY, JANUARY 25, 2021 | THE ASSOCIATED PRESS

https://www.marketbeat.com/articles/the-latest-fema-to-reimburse-states-for-some-pandemic-costs-2021-01-25/?confirmationemail=1

#Coronavirus #AstraZenica #Vaccine

Did AstraZeneca mislead the European Union? | DW News

•Jan 27, 2021 DW News DW News

E.U. vaccine feud with AstraZeneca bursts into the open; Biden vows to boost supply

It’s unclear whether increasing U.S. vaccine numbers will help return schools to in-person learning. A CDC report said that schools haven't been a major center of transmission.By Erin Cunningham and Paul Schemm

‘Solidarity Is Failing’: E.U. and Britain Fight Over Scarce Vaccines

As vaccine production falls behind schedule and the European Union lags in inoculating people, Britain and Europe are lobbing accusations at each other.

EU-Astra Vaccine Dispute Descends Into Chaos Over Crunch Call

January 27 2021

Sanofi to provide support to BioNTech in manufacturing their COVID-19 vaccine to help address public health needs

DOWNLOAD THE PDF VERSION

Sanofi to provide support to BioNTech in manufacturing their COVID-19 vaccine to help address public health needs

Sanofi will provide BioNTech access to its state-of-the-art production infrastructure
From summer 2021, Sanofi will perform late-stage manufacturing to supply over 125 million doses of COVID-19 vaccine for the European Union
This agreement between the two Companies reflects the shared commitment to increase vaccine accessibility

MEDIA UPDATE - JANUARY 27, 2021

https://www.sanofi.com/en/media-room/press-releases/2021/2021-01-27-07-30-00

Pfizer-BioNTech to Make 125 Million New Vaccine Doses in First-Ever Licensing Deal

Sanofi to Make Millions of BioNTech-Pfizer Vaccine Doses

By Tim Loh January 27, 2021, 3:01 AM EST Updated on January 27, 2021, 5:15 AM EST

Collaboration will help boost European Union’s vaccine supply
Companies pledge more than 125 million doses of mRNA shot

https://www.bloomberg.com/news/articles/2021-01-27/sanofi-to-make-millions-of-biontech-pfizer-s-covid-vaccine-doses?srnd=premium

EU-Astra Vaccine Dispute Descends Into Chaos Over Crunch Call
Share of Americans Who Want Covid Vaccine Growing, Poll Finds
Biden’s Moves to Boost Vaccine Supply Won’t Sate Soaring Demand

Teachers are moving to the front of the vaccine line — but that doesn’t mean all schools will reopen quickly

By Hannah Natanson, Donna St. George and Perry Stein

January 27, 2021 at 7:00 AM EST

REGEN-COV™ ANTIBODY COCKTAIL IS ACTIVE AGAINST SARS-COV-2 VARIANTS FIRST IDENTIFIED IN THE UK AND SOUTH AFRICA

TARRYTOWN, N.Y., Jan. 27, 2021 /PRNewswire/ --

Columbia University researchers and Regeneron have independently confirmed findings; data included in bioRxiv paper and submitted for peer-reviewed publication

https://newsroom.regeneron.com/news-releases/news-release-details/regen-covtm-antibody-cocktail-active-against-sars-cov-2-variants

RISK LEVELS
LOW MEDIUM HIGH VERY HIGH EXTREMELY HIGH

See the Risk of Coronavirus in Each of America’s Counties

You can also read county-specific guidance for activities to help lower your personal risk.

‘It is just very disturbing’: City Council wants answers as questions build over severed Philly Fighting COVID partnership

by Ellie Silverman, Ellie Rushing and Oona Goodin-Smith The city said the group failed to promptly disclose its switch to a for-profit business and its privacy policy outlined ways personal information given by residents could be sold.

A Philly private school got COVID-19 vaccines for its teachers. Then its clinic was canceled.

by Jason Laughlin and Maddie Hanna

Springside Chestnut Hill Academy’s aborted effort to vaccinate its staff highlighted the confusion and potential for inequity surrounding the hopes for protection from COVID-19 for school personnel.

Covid Deaths Persist in U.S. Even as Cases Drop Everywhere

Nic Querolo

EU threatens to impose controls on Pfizer vaccine exports

•Jan 26, 2021 Channel 4 News Channel 4 News

New Jersey launched a vaccine hotline. Four hours later, 58,000 calls had flooded in.

https://www.inquirer.com/news/coronavirus-covid-19-pa-nj-philly-vaccine-hotline-deaths-surge-20210125.html

NEW JERSEY
COVID-19 Information Hub

Call (General COVID-19 Questions): 2-1-1 (24/7)
Call (Medical COVID-19 Questions): 1-800-962-1253Medical Information from healthcare professionals on symptoms, when to seek medical attention, and proper steps to take if exposed to COVID-19. (24/7)
Call (Vaccine Appointment Support): 1-855-568-0545 (8a-8p)
Text NJCOVID to 898-211 to receive alerts
Download COVID Alert NJ app here

https://covid19.nj.gov/

Global Cases Top 100 Million; N.J. May Relax Curbs: Virus Update

Bloomberg NewsJanuary 25, 2021, 6:16 PM EST Updated on January 26, 2021, 4:46 PM EST

https://www.bloomberg.com/news/articles/2021-01-25/who-warns-on-vaccine-u-n-issues-call-for-equity-virus-update?srnd=coronavirus

100,000: Why is the UK's death toll so bad?

As the number of people who died reaches six figures, the factors that led to this terrible total. HEALTH

CDC finds scant coronavirus spread in schools, particularly with masks and distancing in place

Some indoor athletics, however, have led to infections and should be curtailed if schools want to operate safely, researchers from the Centers for Disease Control and Prevention concluded in newly published papers. By Laura Meckler

JANUARY 26, 202112:29 PMUPDATED 3 HOURS AGO

Sanofi to help produce 100 million Pfizer/BioNTech vaccine doses

By Reuters Staff PARIS (Reuters)

https://www.reuters.com/article/us-health-coronavirus-vaccines-sanofi/sanofi-to-help-produce-100-million-pfizer-biontech-vaccine-doses-idUSKBN29V23Y?source=content_type%3Areact%7Cfirst_level_url%3Anews%7Csection%3Amain_content%7Cbutton%3Abody_link

Pfizer/ BioNTech to speed up COVID-19 vaccine supply

Jan. 26, 2021 9:28 AM ET Pfizer Inc. (PFE) By: Dulan Lokuwithana, SA News Editor12 Comments

https://seekingalpha.com/news/3654371-pfizer-biontech-to-speed-up-covid-19-vaccine-supply

It will increase the vaccine supply by 20%, Mr. Bourla had said previously, and the FDA issued a label change in that regard last week.
https://twitter.com/BloombergLive/status/1354062624049274885?s=20&source=content_type%3Areact%7Cfirst_level_url%3Anews%7Csection%3Amain_content%7Cbutton%3Abody_link

Facing a scary coronavirus strain, U.K. is running a high-stakes, real-world vaccine experiment

By William Booth and Karla Adam

Darden Offers Paid Time Off for Employees to Get Covid Vaccine

The Pandemic Disaster That Might Not Matter

TOM MCTAGUE 1:00 AM ET

One Pa. county sees sharp spike in cases; city severs partnership with Philly Fighting COVID; Pfizer to deliver vaccine doses to U.S. faster than expected

by Rob Tornoe, Laura McCrystal, Erin McCarthy and Robert Moran

The Pandemic Is Finally Softening. Will That Last?

The pandemic is softening, but the reprieve may not last.

ROBINSON MEYER

#BBC #BBCiPlayer #BBCNews

Covid-19: Vaccine minister 'confident' of supplies 🔴 @BBC News live - BBC

Jan 26, 20212

Pfizer to Deliver U.S. Vaccine Doses Faster Than Expected: CEO

By Riley Griffin January 26, 2021, 8:51 AM EST

https://www.bloomberg.com/news/articles/2021-01-26/pfizer-to-deliver-u-s-vaccine-doses-faster-than-expected-ceo?srnd=premium

New data show treatment with Lilly's neutralizing antibodies bamlanivimab (LY-CoV555) and etesevimab (LY-CoV016) together reduced risk of COVID-19 hospitalizations and death by 70 percent

January 26, 2021Download PDF- BLAZE-1 trial met primary endpoint and key secondary endpoints with high statistical significance
- Results from more than 1,000 high-risk patients were consistent with previous data
- Findings from BLAZE-4 trial provide data on lower doses of bamlanivimab and etesevimab together
- Media and investor call "SARS-CoV-2 Neutralizing Antibody Program Update" to be held at noon EST today; details below

INDIANAPOLIS, Jan. 26, 2021 /PRNewswire/ -- Bamlanivimab (LY-CoV555) 2800 mg and etesevimab (LY-CoV016) 2800 mg together significantly reduced COVID-19-related hospitalizations and deaths (collectively, "events") in high-risk patients recently diagnosed with COVID-19, meeting the primary endpoint of the Phase 3 BLAZE-1 trial, Eli Lilly and Company (NYSE: LLY) announced. Across 1,035 patients, there were 11 events (2.1 percent) in patients taking therapy and 36 events (7.0 percent) in patients taking placebo, representing a 70 percent risk reduction (p= 0.0004). There were 10 deaths total, all of which occurred in patients taking placebo, and no deaths in patients taking bamlanivimab and etesevimab together.

https://investor.lilly.com/news-releases/news-release-details/new-data-show-treatment-lillys-neutralizing-antibodies

Eli Lilly (LLY -0.02%) reports new data from Phase 3 Blaze-1 trial, evaluating bamlanivimab and etesevimab antibody combination in critically-ill COVID-19 patients.

A Study of LY3819253 (LY-CoV555) and LY3832479 (LY-CoV016) in Participants With Mild to Moderate COVID-19 Illness (BLAZE-1)

https://clinicaltrials.gov/ct2/show/NCT04427501

Can India outshine China with Covid-19 vaccine diplomacy?

India is donating millions of AstraZeneca shots to countries including Bangladesh, Sri Lanka, Nepal and Mauritius
New Delhi says 92 nations including Cambodia, a close ally of Beijing, are interested in vaccines produced by the Serum Institute of India

Subir Bhaumik Published: 12:05pm, 26 Jan, 2021

https://www.scmp.com/week-asia/health-environment/article/3119194/can-india-outshine-china-covid-19-vaccine-diplomacy

In U.K., Concern Grows Over Vaccine Hesitancy Among Minority Groups

There are increasing calls to prioritize people of color, who have been harder hit. But many mistrust the authorities — and the shots’ safety.

Biden now hopes for 1.5 million vaccinations a day, a big jump from earlier comments

On Monday, President Biden said he could envision 1.5 million U.S. vaccinations per day. The recalibration reflects the reality that the country is already close to the million-a-day pace. By Annie Linskey

U.S. Falters in DNA Testing to Detect Dangerous Covid Mutations

Surging Covid Cases Shut Down Thai Conglomerate’s Northeast China Unit

More than 100 positive cases have been identified in the city of Harbin, all of which are thought to be linked to a local food production subsidiary of CP Group

Jan 26, 2021 07:24 PM

Explainer | How the Covid-19 vaccines compare and who can get them

The race to carry out the biggest inoculation programme in history has begun, with six products approved and more to follow.

Indonesia hits 1 million cases; Australians defy Covid-19 curbs

Elsewhere, New Zealand is closing in on approving a Covid-19 vaccine, and the Serum Institute of India says it has no plans to divert vaccine supplies to Europe despite production problems there.

Moderna says vaccine works against new Covid-19 variants

Lab tests show shot produces comparable antibody protection against UK strain, but immunity may wane more quickly for South Africa variant.

26 Jan 2021 - 2:00PM

STOPPING THE NEXT ONE | INFECTIOUS DISEASE

The coronavirus 10 times more deadly than Covid

By Jacob Kushner in Marsabit, Kenya 25th January 2021

In northern Kenya, researchers are working to prevent a dangerous coronavirus – Mers – from jumping from camels to humans again. But climate change is making their job more difficult.

https://www.bbc.com/future/article/20210122-the-coronavirus-10-times-more-deadly-than-covid

#CNBC #CNBCTV

Florida tightens Covid-19 vaccination requirements across the state

•Jan 25, 2021 CNBC Television CNBC Television

Life after the COVID-19 vaccine: Americans won’t rush back to restaurants and ballgames — or public transportation

Last Updated: Jan. 25, 2021 at 6:16 p.m. ET First Published: Jan. 25, 2021 at 11:07 a.m. ET

By Elisabeth Buchwald

‘The arrival of vaccines won’t automatically flip a switch to put the world back on its pre-COVID path,’ said Scott McKenzie, global intelligence leader at Nielsen

https://www.marketwatch.com/story/life-after-the-covid-19-vaccine-americans-wont-rush-back-to-restaurants-ball-games-or-public-transportation-11611590839?mod=home-page

Coronavirus: Germany to use new antibody-based drug

Health Minister Jens Spahn has said the government has purchased a new drug to help fight COVID-19 amid a vaccine shortage. Germany will be the first EU nation to use the medicine, which was also given to Donald Trump.

https://www.dw.com/en/coronavirus-germany-to-use-new-antibody-based-drug/a-56328493?source=content_type%3Areact%7Cfirst_level_url%3Anews%7Csection%3Amain_content%7Cbutton%3Abody_link

Developing our Novel Anti-Viral Antibody Cocktail

Casirivimab and imdevimab form a novel monoclonal antibody cocktail being studied for its potential both to treat appropriate patients with COVID-19 and to prevent SARS-CoV-2 infection.

Casirivimab and imdevimab are investigational therapies and have been authorized by the FDA for the emergency use described below. Casirivimab and imdevimab must be administered together. Casirivimab and imdevimab are not FDA approved for any use. Safety and effectiveness of casirivimab and imdevimab have not been fully established for the treatment of COVID-19.

https://www.regeneron.com/covid19

California Lifts Stay-at-Home Orders in Much of the State

Officials lifted severe virus restrictions in many areas, allowing some outdoor dining and personal care businesses to reopen. Here’s the latest on Covid-19.

Schools Were Set to Reopen. Then the Teachers’ Union Stepped In.

Students didn’t return to elementary schools in Montclair, N.J., as planned after a tense debate and a boycott of prep sessions by some educators.

First U.S. case of Brazil variant identified in Minnesota

State health authorities said the case of the highly transmissible variant involved “a Minnesota resident with recent travel history to Brazil” and was detected through random surveillance of blood samples. By Joel Achenbach

N.Y. to Start Easing Curbs; Dutch Riot Over Curfew: Virus Update

As Virus Grows Stealthier, Vaccine Makers Reconsider Battle Plans

Vaccines by Moderna and Pfizer-BioNTech protect recipients. But in a worrying sign, they are slightly less effective against a variant found in South Africa.

Florida reports 153 coronavirus resident deaths, 8,720 new cases

Florida’s resident death toll from coronavirus rose to 25,446 with the addition of 153 more reported fatalities on Monday while also adding 8,720 more positive COVID-19 cases to bring the total to 1,658,169.By RICHARD TRIBOU

Moderna Is Working on a Vaccine Booster for a New Variant

Moderna vaccine protects against British, S. African variants, company says

By Carolyn Y. Johnson

Fauci Says He’s Worried About Delaying Second Vaccine Dose

Thomas Mulier and Corinne Gretler

An Organ Recital, With a Coronavirus Shot

Salisbury Cathedral is joining Britain’s vaccination drive, and its organists are providing a musical accompaniment. They’re even taking requests.

New coronavirus variants are an urgent threat. Here’s what you need to know

Skelton: It shouldn’t be this hard getting COVID-19 vaccine into people’s arms

One Country Has Jumped Ahead on Vaccinations

URI FRIEDMAN JANUARY 23, 2021

Google to invest millions in coronavirus vaccine education and access

Coronavirus crisis: Vaccine rollout grows amid travel ban and variant concerns

•Jan 25, 2021 ABC News ABC News

Jan 25, 2021 07:57 PM CHINA

Leading Chinese Drug Researcher Calls for Greater Transparency on China Vaccines

By Wang Lijun, Wang Zhuoqing and Timmy Shen

https://www.caixinglobal.com/2021-01-25/leading-chinese-drug-researcher-calls-for-greater-transparency-on-china-vaccines-101655572.html

JANUARY 25, 202110:13 AM UPDATED 3 HOURS AGO

Exclusive: Pfizer wants India to order COVID-19 vaccine before pursuing approval

By Krishna N. Das NEW DELHI (Reuters)

https://www.reuters.com/article/health-coronavirus-india-pfizer-idUSKBN29U1OA?source=content_type%3Areact%7Cfirst_level_url%3Anews%7Csection%3Amain_content%7Cbutton%3Abody_link

Virus Variants Push Nations to Lock Down and Zip Up Borders

NYC to Miss 1 Million-Shot Goal, Delay Megasites Amid Shortage

“We’re not going to be able to soar until we get more supply,” Mayor de Blasio says.

How West Virginia Became a U.S. Leader in Vaccine Rollout

About 9 percent of all West Virginians have received a first dose of the coronavirus vaccine, a larger segment than almost every other state.

President Biden Is Vowing to Reopen Schools Quickly. It Won’t Be Easy.

Fights between districts and unions — as well as fear among teachers and parents — could make it hard to fulfill the promise.

To Promote Shot, New Orleans Dances With Heart on Sleeve

An upbeat ‘Sleeves Up, NOLA’ campaign deftly uses local personalities and the Carnival dance culture to encourage citizens to get a Covid-19 vaccine.

Pandemic aftershocks overwhelm global supply lines, threatening higher prices for consumers

By David J. Lynch

Global Crisis Damage From Covid-19 Is Now About 255 Million Jobs

Even under the most optimistic assumptions, working hours will still be lower compared to pre-crisis levels.

Deborah Birx said Trump was being given ‘parallel data’ on covid-19

By Teo Armus

Moderna Developing Booster Shot Against South Africa Strain

Moderna said its Covid-19 vaccine appeared to protect against emerging strains in lab tests, but due to a weaker immune response, the company will develop a booster shot targeting the variant first identified in South Africa.

Coronavirus: EU locks horns with AstraZeneca on vaccine deliveries amid ‘supply shock’

The drug maker is struggling to meet supply targets up to the end of March
Australia and Thailand are among countries that face supply cuts, with the latter to get some 150,000 doses instead of the 1 million it had initially requested

Reuters Published: 11:52pm, 25 Jan, 2021

https://www.scmp.com/news/world/europe/article/3119208/eu-urges-astrazeneca-hasten-covid-19-vaccine-deliveries-amid

Oxygen Scarcity Swells Covid-19’s Death Toll

As Covid-19 cases increase sharply in much of the world, a scarcity of oxygen is forcing hospitals to ration it for patients. The problem is especially acute in the developing world, but has also hit hospitals in London and Los Angeles.

Covid-19 Vaccine: What You Need to Know When You Get the Shot

Doctors answer questions about preparing for the Covid-19 vaccine

By Alina Dizik Updated Jan. 23, 2021 4:01 pm ET

https://www.wsj.com/articles/covid-19-vaccine-what-you-need-to-know-when-you-get-the-shot-11610895600?mod=trending_now_pos3

Why Delaying the Second Covid Vaccine Shot Is Messy

John Lauerman and Jason Gale 1/25/21, 2:43 AM EST

A Guide to the New Covid-19 Testing Rules for Travel to the U.S.

The CDC will require preflight testing as Covid-19 cases continue to soar and new strains of the virus emerge

By Alison Sider Updated Jan. 22, 2021 2:59 pm ET

https://www.wsj.com/articles/the-new-covid-19-testing-rules-for-travel-to-the-u-s-what-they-mean-for-you-11610566341?mod=trending_now_pos2

U.S. to Boost Surveillance of Virus Variants, CDC Head Says

Tony Czuczka and Craig Torres 1/24/21, 1:15 PM EST

#nanographics #visualization #biology

What does a virus actually look like?

1Jan 18, 2021 Too Dope for Microscope

Real SARS-CoV-2 virion in 3D

What does a virus actually look like?

This is the first time you can see real (flash-frozen) coronavirus in 3D. We used machine learning and advanced visualization algorithms to show you the most detailed view of a real SARS-CoV-2 virion, in 3D, directly from Cryo-ET data.

https://nanographics.at/projects/coronavirus-3d/
https://nanographics.at/

The Cryo-ET data were provided by Sai Li of Tsinghua University, Beijing, China.

https://www.tsinghua.edu.cn/en/index.htm

The structure of the novel coronavirus SARS-CoV-2

•Apr 30, 2020

https://www.youtube.com/watch?v=IB3ujgoniVQ&feature=emb_logo

Coronavirus SARS-CoV-2

https://nanographics.at/projects/sars-cov-2/

First 3D scan of the real coronavirus revealed

•Jan 25, 2021
South China Morning Post South China Morning Post

Real SARS-CoV-2 virion in 3D

What does a virus actually look like?

https://nanographics.at/projects/coronavirus-3d/
https://nanographics.at/

The Cryo-ET data were provided by Sai Li of Tsinghua University, Beijing, China.

https://www.tsinghua.edu.cn/en/index.htm

Covid-19 pandemic: in-depth analysis one year after Wuhan

Updated: 15 Jan 2021

https://www.scmp.com/news/china/series/3113354/covid-19-pandemic-depth-analysis-one-year-after-wuhan?module=coivd_table&pgtype=homepage

novel coronavirus (2019-nCoV) 病毒：新型冠状病毒 2019-nCoV

Doctors' leaders warn vaccine second dose delay may "undermine effectiveness" - BBC News

•Jan 23, 2021 BBC News BBC News

Why Delaying the Second Covid Vaccine Shot Is Messy

Surge of Student Suicides Pushes Las Vegas Schools to Reopen

Firmly linking teen suicides to school closings is difficult, but rising mental health emergencies and suicide rates point to the the pandemic lockdown’s toll.

Economics World’s Economic Recovery Gets Delayed by Slow Vaccine Rollouts

What if You Never Get Better From Covid-19?

Some patients could live with the aftereffects for years. Research into another persistent, mysterious disease might help us understand how to treat them.

“An incredible scale of tragedy”: The U.S. has surpassed 25 million coronavirus cases. Catch up on the latest.

As more people become eligible to get vaccinated in the region, dosage supply remains an issue

Canceled appointments, long waits and uncertainty about future vaccine shipments dominate. By Jenna Portnoy

Moderna COVID-19 Vaccine Retains Neutralizing Activity Against Emerging Variants First Identified in the U.K. and the Republic of South Africa

January 25, 2021 at 8:28 AM ESTPDF Version

Out of an abundance of caution, Moderna launches clinical program to boost immunity to emerging variants

Manuscript posted to preprint server; company to host conference call once manuscript is available

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Jan. 25, 2021-- Moderna Inc. (Nasdaq: MRNA)

https://investors.modernatx.com/news-releases/news-release-details/moderna-covid-19-vaccine-retains-neutralizing-activity-against

Vaccines May Work Less Well on Variants, U.K.’s Hancock Says

Joe Mayes 1/24/21, 5:41 AM EST

Coronavirus updates: 17% of US has been infected, model estimates; Capitol Police, National Guard outbreaks reported

Grace Hauck USA TODAY Updated 4:02 PM ET January 23, 2021

https://www.usatoday.com/story/news/health/2021/01/23/covid-cases-updates-larry-king-dies-after-being-hospitalized-covid-19/6674844002/

FDA gives approval for syringes to extract an extra dose from vials of Covid-19 vaccine

By Travis Caldwell, Dakin Andone and Jason Hanna, CNN updated 0442 GMT (1242 HKT) January 24, 2021

https://edition.cnn.com/2021/01/23/us/us-coronavirus-saturday/index.html?source=content_type%3Areact%7Cfirst_level_url%3Anews%7Csection%3Amain_content%7Cbutton%3Abody_link

Pfizer/BioNTech COVID-19 vaccine supply to rise with FDA label change

Jan. 23, 2021 11:48 PM ET Pfizer Inc. (PFE) By: Dulan Lokuwithana, SA News Editor11 Comments

The FDA has approved an updated label for Pfizer (NYSE:PFE)/BioNTech (NASDAQ:BNTX)

https://seekingalpha.com/news/3653734-pfizerbiontech-covid-19-vaccine-supply-to-rise-with-fda-label-change

COVID-19 vaccination: CDC guidance updated; Case counts decline

Jan. 23, 2021 10:59 PM ET Pfizer Inc. (PFE) By: Dulan Lokuwithana, SA News Editor42 Comments

The Centers for Disease Control and Prevention (“CDC”) has updated the guidance in COVID-19 vaccination allowing the two vaccines currently approved in the U.S. to use interchangeably in rare cases. The updated clinical considerations posted on Friday also allow the follow-up dose of the two-dose regimen to delay up to six weeks.

https://seekingalpha.com/news/3653733-covid-19-vaccination-cdc-guidance-updated-case-counts-decline

Interchangeability with other COVID-19 vaccine products

https://www.cdc.gov/vaccines/covid-19/info-by-product/clinical-considerations.html?source=content_type%3Areact%7Cfirst_level_url%3Anews%7Csection%3Amain_content%7Cbutton%3Abody_link#Interchangeability

#CNBC #CNBCTV

Dr. Scott Gottlieb on Covid-19 vaccine distribution, case counts and new variants

•Jan 22, 2021 CNBC Television CNBC Television

seeking biotech alpha is biotecMAX 生物技术最大 9/24/2021 the heart of biotech

novel coronavirus (2019-nCoV) 病毒：新型冠状病毒 2019-nCoV

Johnson & Johnson recommended - AstraZeneca questioned | DW News

BioNTech Recruits Rivals to Boost Covid-19 Vaccine Production

German company enlists other firms as its partner, Pfizer, struggles to meet production targets

Immunity passports can speed up return to normality | COVID-19 Special

'Vaccine diplomacy': How China is capitalizing on the COVID crisis

Coronavirus: Chile overtakes Israel as fastest country to vaccinate

Chile vaccinating its population at a rate that beats other countries Thursday marks first anniversary of WHO’s declaration of pandemic

Has the COVID-19 pandemic increased inequality against women? | COVID-19 Special

Pfizer/BioNTech COVID-19 vaccine neutralizes Brazil variant in lab study

Those We’ve Lost

German government loses support on coronavirus policies +++ US ramps up vaccination drive | DW News

‘Chinese virus, get out!’: lecturer from China beaten in Britain amid spike in hate crimes

Peng Wang, who teaches at the University of Southampton, suffered face and arm injuries after being beaten by four men while jogging near his home Reports of race crime against people of East Asian appearance in Britain have soared in the past year

WSJ Investigation: As Workers Faced Covid Risks, OSHA Fell Short of Its Mission | WSJ

How the different Covid vaccines will handle new variants of the virus

U.S. Government Scientists Skeptical of One-Shot Regimen for Pfizer, Moderna Covid Vaccines

Some members of Congress have urged to allow for just one dose to speed up vaccinations

What You Can and Can’t Do if You’ve Been Vaccinated: Travel, Gatherings, Risk Factors, What You Need to Know

Until we reach herd immunity, vaccinated people must navigate some complicated decision-making. Here’s how to assess the risks.

Number of COVID-19 deaths in the United States as of March 4, 2021, by state

How the Novavax coronavirus vaccine uses moth cells

Did coronavirus jump to humans through trade in exotic animals in China? | COVID-19 Special

WHO Investigators to Scrap Plans for Interim Report on Probe of Covid-19 Origins

U.S-China tensions rise over investigation as group of scientists presses for fresh inquiry, including into lab escape theory

Largest Vaccine Maker Warns of Delays as U.S. Prioritizes Pfizer

Comparing Johnson & Johnson Vaccine to Pfizer And Moderna | NBC News NOW

Bergamo, where the horrors of COVID-19 in Europe started | DW News

Exclusive: Oxford study indicates AstraZeneca effective against Brazil variant, source says

India-EU push to temporarily ban vaccine patents | Coronavirus Vaccine | Latest English News | WION

Europe fears creating COVID-19 vaccine passports could lead to discrimination, division

If you’ve hit a pandemic ‘wall,’ you’re not alone. Here’s how to cope. | Expert Opinion

Covid: Germany approves AstraZeneca vaccine for over-65s

Covid19 UK: What impact will the Brazil variant have? - BBC Newsnight

Virus Transmission Levels by County in Pa.

COVID-19 Early Warning Monitoring System Dashboard

novel coronavirus (2019-nCoV) 病毒：新型冠状病毒 2019-nCoV

Brazilian Covid strain found in UK raising fears over vaccine protection - BBC News

Chile vaccinating its population at a rate that beats other countries
Thursday marks first anniversary of WHO’s declaration of pandemic

Peng Wang, who teaches at the University of Southampton, suffered face and arm injuries after being beaten by four men while jogging near his home
Reports of race crime against people of East Asian appearance in Britain have soared in the past year